Evidence map›Paper›PMID 29535525›Full record

ArticleTherapeutics and clinical risk management2018

Clinical and economic burden of procedural sedation-related adverse events and their outcomes: analysis from five countries.

Rhodri Saunders, Jason A Davis, Peter Kranke, Rachel Weissbrod, David K Whitaker, Jenifer R Lightdale

Abstract read
In one paragraph

Article in Therapeutics and clinical risk management, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Sedation reversal trends at outpatient ambulatory endoscopic centerWorld journal of gastrointestinal endoscopy · 2024
    Trial
  3. Trial
  4. Preoperative Imaging for Cochlear Implantation: A Global Consensus.Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Evaluating Remimazolam for Procedural Sedation.Current neuropharmacology · 2025
    Review
  9. Article
  10. Up-to-date literature review and issues of sedation during digestive endoscopy.Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques · 2023
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rhodri SaundersCoreva Scientific GmbH & Co KG, Freiburg, Germany.
Jason A DavisCoreva Scientific GmbH & Co KG, Freiburg, Germany.
Peter KrankeDepartment of Anaesthesia and Critical Care, University of Würzburg, Würzburg, Germany.
Rachel WeissbrodMedical Affairs, Medtronic, Jerusalem, Israel.
David K WhitakerDepartment of Anaesthesia, Manchester Royal Infirmary, Manchester, UK.
Jenifer R LightdalePediatric Gastroenterology, Hepatology and Nutrition, University of Massachusetts, Worcester, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundStudies have reported on the incidence of sedation-related adverse events (AEs), but little is known about their impact on health care costs and resource use.

methodsHealth care providers and payers in five countries were recruited for an online survey by independent administrators to ensure that investigators and respondents were blinded to each other. Surveys were conducted in the local language and began with a "screener" to ensure that respondents had relevant expertise and experience. Responses were analyzed using Excel and R, with the Dixon's

resultsResponses were received from 101 providers and 26 payers, the majority having >5 years of experience. At a minimum, the respondents performed a total of 3,430 procedural sedations per month. All AEs detailed occurred in clinical practice in the last year and were reported to cause procedural delays and cancellations in some patients. Standard procedural sedation costs ranged from €74 (Germany) to $2,300 (US). Respondents estimated that AEs would increase costs by between 16% (Italy) and 179% (US). Hypotension was reported as the most commonly observed AE with an associated global mean cost (interquartile range) of $43 ($27-$68). Other frequent AEs, including mild hypotension, bradycardia, tachycardia, mild oxygen desaturation, hypertension, and brief apnea, were estimated to increase health care spending on procedural sedation by $2.2 billion annually in the US.

conclusionAll sedation-related AEs can increase health care costs and result in substantial delays or cancellations of subsequent procedures. The prevention of even minor AEs during procedural sedation may be crucial to ensuring its value as a health care service.

Indexed as

complicationscostshealth care payersmoderate sedationquestionnairesurvey

Identifiers

PMID29535525
PMCPMC5836671

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.